Who Supplies Melphalan to India from CANADA

To import finished pharmaceutical formulations containing Melphalan into India, manufacturers must obtain an Import Registration Certificate and an Import License from the Central Drugs Standard Control Organization (CDSCO). The application process involves submitting Form 40/41, along with a fee of $1,000 USD per drug, and providing a Certificate of Pharmaceutical Product (CoPP) and a Good Manufacturing Practice (GMP) certificate. The registration is valid for three years. The timeline for approval varies but typically ranges from 6 to 12 months, depending on the completeness of the application and compliance with regulatory requirements.

Imported Melphalan formulations must undergo quality testing at CDSCO-approved laboratories. Each batch requires a Certificate of Analysis (CoA) confirming compliance with Indian Pharmacopoeia standards. Stability data, adhering to ICH Zone IV guidelines, must be provided to demonstrate the product's shelf-life under Indian climatic conditions. Port inspections by customs drug inspectors are mandatory to verify the authenticity and quality of the imported goods.

In April 2025, the Indian government introduced new regulations mandating import registration and licensing for all imported medicines, including finished formulations containing Melphalan. This policy aims to prevent the sale of unapproved or illegal medicines in the Indian market. The regulations require compliance with the Drugs and Cosmetics Act and associated rules, ensuring that imported drugs meet quality, safety, and efficacy standards.

India imports finished Melphalan formulations to meet the therapeutic needs of patients, particularly for cancer treatments. The demand is driven by the availability of patented or branded formulations, specific dosage forms not produced domestically, and the need for high-quality products. The market size for Melphalan formulations in India is substantial, with imports totaling $12.8 million across 153 exporters to 97 countries.

The Basic Customs Duty (BCD) for HS Code 30049049 is 10%. Additionally, a Social Welfare Surcharge (SWS) of 10% is applied. The Integrated Goods and Services Tax (IGST) rate varies based on the product's classification and applicable GST rates. There are no additional duties or exemptions for goods originating from Canada.

India sources finished Melphalan formulations from Canada due to the high quality and compliance with international standards. Canadian manufacturers offer patented formulations and specialized dosage forms not available domestically. While other suppliers like China, Germany, and the United States also export Melphalan formulations to India, Canada's share remains significant, reflecting its competitive advantage in quality and innovation.

India imports finished Melphalan formulations from Canada due to the availability of patented formulations, specialized dosage forms, and high-quality products that meet international standards. Canadian manufacturers offer formulations not produced domestically, fulfilling specific therapeutic needs in the Indian market.

Compared to other origins like China, the European Union, and the United States, Canada offers a competitive advantage in terms of product quality, regulatory compliance, and innovation. While other suppliers may offer lower prices, Canada's adherence to international standards and the availability of specialized formulations make it a preferred source for Indian importers.

Indian importers face risks such as single-source dependency, currency fluctuations, regulatory changes, quality incidents, and shipping disruptions. Past shortages have occurred due to global supply chain issues, emphasizing the need for strategic sourcing and risk management.

1. 1Dual-Sourcing: Engage multiple suppliers to mitigate single-source risks.
2. 2Inventory Planning: Maintain adequate stock levels to buffer against supply chain disruptions.
3. 3Payment Terms: Negotiate favorable terms such as Letters of Credit (LC), Documents Against Acceptance (DA), or Documents Against Payment (DP).
4. 4Minimum Order Quantities (MOQs): Align order sizes with demand forecasts to optimize inventory costs.
5. 5Supplier Qualification: Conduct thorough due diligence to ensure supplier reliability and compliance with regulatory standards.

1. 1DGFT Importer Exporter Code (IEC): Obtain an IEC from the Directorate General of Foreign Trade.
2. 2CDSCO Form 40/41: Submit the application for import registration.
3. 3Drug Import License: Secure the license from CDSCO.
4. 4No Objection Certificate (NOC): If applicable, obtain an NOC from the manufacturer.
5. 5Customs Broker: Engage a licensed customs broker for clearance procedures.
6. 6Advance Ruling: Seek an advance ruling for HS Code 30049049 to confirm classification and duty rates.

1. 1Certificate of Analysis (CoA): Confirming product quality and compliance.
2. 2Certificate of Pharmaceutical Product (CoPP): Indicating regulatory approval in the country of origin.
3. 3Good Manufacturing Practice (GMP) Certificate: Demonstrating adherence to international manufacturing standards.
4. 4Drug Master File (DMF): Providing detailed information on the drug substance.
5. 5Stability Data: Adhering to ICH Zone IVa/IVb guidelines.
6. 6Free Sale Certificate: Indicating the product is freely sold in the country of origin.